{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:22:29Z","timestamp":1786123349525,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1213\/ane.0b013e3181bef685","type":"journal-article","created":{"date-parts":[[2009,11,16]],"date-time":"2009-11-16T03:14:58Z","timestamp":1258341298000},"page":"1715-1717","source":"Crossref","is-referenced-by-count":6,"title":["The Next Generation of Colloids: Ready for \u201cPrime Time\u201d?"],"prefix":"10.1213","volume":"109","author":[{"given":"Nancy A.","family":"Nussmeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Searles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210902","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00000542-200408000-00055","article-title":"Why the Food and Drug Administration changed the warning label for hetastarch.","volume":"101","author":"Haynes","year":"2004","journal-title":"Anesthesiology"},{"key":"R2-1-20210902","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1213\/ANE.0b013e3181b5a24b","article-title":"Cardiopulmonary bypass priming using a high-dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.","volume":"109","author":"Boldt","year":"2009","journal-title":"Anesth Analg"},{"key":"R3-1-20210902","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/ACO.0b013e32830dd05b","article-title":"Saline versus balanced hydroxyethyl starch: does it matter?","volume":"21","author":"Boldt","year":"2008","journal-title":"Curr Opin Anaesthesiol"},{"key":"R4-1-20210902","first-page":"411","article-title":"Cardiopulmonary bypass principles and practice. 3rd ed.","author":"Cooper","year":"2008"},{"key":"R5-1-20210902","first-page":"99","article-title":"Techniques in extracorporeal circulation. 4th ed.","author":"Boonstra","year":"2004"},{"key":"R6-1-20210902","first-page":"260","article-title":"Heart-lung bypass: principles and techniques of extracorporeal circulation.","author":"Galleti","year":"1962"},{"key":"R7-1-20210902","first-page":"46","article-title":"Extracorporeal circulation for open-heart surgery: pathophysiology, apparatus and methods including the special techniques of hypothermia and hyperbaric oxygenation.","author":"Peirce","year":"1969"},{"key":"R8-1-20210902","first-page":"214","article-title":"Cardiopulmonary perfusion.","author":"Reed","year":"1975"},{"key":"R9-1-20210902","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00003246-200106000-00038","article-title":"Effects of different plasma substitutes on blood coagulation: a comparative review.","volume":"29","author":"de Jonge","year":"2001","journal-title":"Crit Care Med"},{"key":"R10-1-20210902","first-page":"221","article-title":"Cardiopulmonary bypass principles and management.","author":"Tobias","year":"1986"},{"key":"R11-1-20210902","first-page":"14743","article-title":"Gelatin.","volume":"43","year":"1978","journal-title":"Fed Regist"},{"key":"R12-1-20210902","first-page":"124","article-title":"Cardiopulmonary bypass principles and practice. 1st ed.","author":"Cooper","year":"1993"},{"key":"R13-1-20210902","first-page":"71","article-title":"On bypass advanced perfusion techniques.","author":"Frumento","year":"2008"},{"key":"R14-1-20210902","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archsurg.139.5.552","article-title":"A systematic review of the comparative safety of colloids.","volume":"139","author":"Barron","year":"2004","journal-title":"Arch Surg"},{"key":"R15-1-20210902","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1378\/chest.123.6.1853","article-title":"Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery.","volume":"123","author":"Sedrakyan","year":"2003","journal-title":"Chest"},{"key":"R16-1-20210902","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0003-4975(01)02745-X","article-title":"Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding.","volume":"72","author":"Wilkes","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"R17-1-20210902","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1017\/S0265021506000639","article-title":"Renal impact of fluid management with colloids: a comparative review.","volume":"23","author":"Davidson","year":"2006","journal-title":"Eur J Anaesthesiol"},{"key":"R19-1-20210902","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.jvca.2007.02.017","article-title":"Con: use of colloids in cardiac surgery.","volume":"21","author":"Nuttall","year":"2007","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R20-1-20210902","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1053\/j.jvca.2006.04.011","article-title":"Fluid management in cardiac surgery: is one hydroxyethyl starch solution safer than another?","volume":"20","author":"Haynes","year":"2006","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R21-1-20210902","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00508-004-0237-3","article-title":"Hydroxyethyl starch\u2014can the safety problems be ignored?","volume":"116","author":"Wiedermann","year":"2004","journal-title":"Wien Klin Wochenschr"},{"key":"R22-1-20210902","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/j.jvca.2007.02.020","article-title":"Pro: use of colloids in cardiac surgery.","volume":"21","author":"Boldt","year":"2007","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R23-1-20210902","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1213\/ane.0b013e31819e9e6c","article-title":"Modern rapidly degradable hydroxyethyl starches: current concepts.","volume":"108","author":"Boldt","year":"2009","journal-title":"Anesth Analg"},{"key":"R24-1-20210902","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00000542-200509000-00031","article-title":"Effects of hydroxyethyl starch solutions on hemostasis.","volume":"103","author":"Kozek-Langenecker","year":"2005","journal-title":"Anesthesiology"},{"key":"R25-1-20210902","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/bja\/ael333","article-title":"Effects of hydroxyethyl starch administration on renal function in critically ill patients.","volume":"98","author":"Sakr","year":"2007","journal-title":"Br J Anaesth"},{"key":"R26-1-20210902","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/bja\/aen353","article-title":"Influence on coagulation of a potato-derived hydroxethylstarch (HES 130\/0.42) and a maize-derived hydroxethylstarch (HES 130\/0.4) in patients undergoing cardiac surgery.","volume":"102","author":"Boldt","year":"2009","journal-title":"Br J Anaesth"},{"key":"R27-1-20210902","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00000542-200307000-00010","article-title":"Large-dose hydroxyethyl starch 130\/0\/4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200\/0.5 at recommended doses.","volume":"99","author":"Kasper","year":"2003","journal-title":"Anesthesiology"},{"key":"R28-1-20210902","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/jcan.2001.23276","article-title":"Influence of a new hydroxyethylstarch preparation (HES 130\/0.4) on coagulation in cardiac surgical patients.","volume":"15","author":"Haisch","year":"2001","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R29-1-20210902","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/BF03019870","article-title":"A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery.","volume":"47","author":"Gallandat-Huet","year":"2000","journal-title":"Can J Anaesth"},{"key":"R30-1-20210902","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1097\/01.CCM.0000288101.02556.DE","article-title":"Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin.","volume":"35","author":"Boldt","year":"2007","journal-title":"Crit Care Med"},{"key":"R31-1-20210902","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/bja\/aen016","article-title":"Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients.","volume":"100","author":"Boldt","year":"2008","journal-title":"Br J Anaesth"},{"key":"R32-1-20210902","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1213\/ane.0b013e31818370b2","article-title":"Is albumin administration in hypoalbuminemic elderly cardiac surgery patients of benefit with regard to inflammation, endothelial activation, and long-term kidney function?","volume":"107","author":"Boldt","year":"2008","journal-title":"Anesth Analg"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e3181bef685","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:14:58Z","timestamp":1786112098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200912000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181bef685","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}